Seeking Alpha

Celldex Therapeutics misses by $0.05

  • Celldex Therapeutics (CLDX): Q3 EPS of -$0.29 misses by $0.05.
  • Revenue of $1.0M beats by $0.1M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)